Page last updated: 2024-09-05

lixivaptan and furosemide

lixivaptan has been researched along with furosemide in 2 studies

Compound Research Comparison

Studies (lixivaptan)	Trials (lixivaptan)	Recent Studies (post-2010) (lixivaptan)	Studies (furosemide)	Trials (furosemide)	Recent Studies (post-2010) (furosemide)
80	10	26	13,631	1,358	2,486

Protein Interaction Comparison

Protein	Taxonomy	furosemide (IC50)
Corticosteroid 11-beta-dehydrogenase isozyme 1	Homo sapiens (human)	3.76
Corticosteroid 11-beta-dehydrogenase isozyme 1	Mus musculus (house mouse)	3.76
Broad substrate specificity ATP-binding cassette transporter ABCG2	Homo sapiens (human)	3.2

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Laczi, F	1
Haass, M	1

Reviews

2 review(s) available for lixivaptan and furosemide

Article	Year
[Etiology, diagnostics and therapy of hyponatremias]. Orvosi hetilap, 2008, Jul-20, Volume: 149, Issue:29 Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins	2008
[Vasopressin receptor antagonists and heart failure]. Therapeutische Umschau. Revue therapeutique, 2009, Volume: 66, Issue:11 Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Furosemide; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Indoles; Male; Morpholines; Platelet Aggregation Inhibitors; Pyrroles; Pyrrolidines; Sodium Potassium Chloride Symporter Inhibitors; Spiro Compounds; Time Factors; Tolvaptan	2009

Article

Year

[Etiology, diagnostics and therapy of hyponatremias].

Orvosi hetilap, 2008, Jul-20, Volume: 149, Issue:29

Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins

2008

[Vasopressin receptor antagonists and heart failure].

Therapeutische Umschau. Revue therapeutique, 2009, Volume: 66, Issue:11

Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Furosemide; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Indoles; Male; Morpholines; Platelet Aggregation Inhibitors; Pyrroles; Pyrrolidines; Sodium Potassium Chloride Symporter Inhibitors; Spiro Compounds; Time Factors; Tolvaptan

2009